Cross-protection and cross-feeding between Klebsiella pneumoniae and Acinetobacter baumannii promotes their co-existence.
Lucie SemenecAmy K CainCatherine J DawsonQi LiuHue DinhHannah LottAnahit PenesyanRam MaharjanFrancesca L ShortKarl A HassanIan T PaulsenPublished in: Nature communications (2023)
Acinetobacter baumannii and Klebsiella pneumoniae are opportunistic pathogens frequently co-isolated from polymicrobial infections. The infections where these pathogens co-exist can be more severe and recalcitrant to therapy than infections caused by either species alone, however there is a lack of knowledge on their potential synergistic interactions. In this study we characterise the genomes of A. baumannii and K. pneumoniae strains co-isolated from a single human lung infection. We examine various aspects of their interactions through transcriptomic, phenomic and phenotypic assays that form a basis for understanding their effects on antimicrobial resistance and virulence during co-infection. Using co-culturing and analyses of secreted metabolites, we discover the ability of K. pneumoniae to cross-feed A. baumannii by-products of sugar fermentation. Minimum inhibitory concentration testing of mono- and co-cultures reveals the ability for A. baumannii to cross-protect K. pneumoniae against the cephalosporin, cefotaxime. Our study demonstrates distinct syntrophic interactions occur between A. baumannii and K. pneumoniae, helping to elucidate the basis for their co-existence in polymicrobial infections.
Keyphrases
- multidrug resistant
- acinetobacter baumannii
- klebsiella pneumoniae
- gram negative
- antimicrobial resistance
- drug resistant
- escherichia coli
- pseudomonas aeruginosa
- staphylococcus aureus
- ms ms
- cystic fibrosis
- respiratory tract
- climate change
- early onset
- rna seq
- mesenchymal stem cells
- biofilm formation
- risk assessment
- drug induced
- cell therapy
- smoking cessation
- single cell
- genetic diversity